ANXA1 and glioblastoma: Subsequently, the TIMER tool was used to estimate the association between the expression of ANXA1 in GBM and the abundance of six immune cell types, including B, CD4+ T, CD8+ T cells, neutrophils, macrophages and myeloid DCs.